SPOTLIGHT: The best pharma stocks of 2007

 
When it comes to picking stocks, prediction may be murky, but hindsight is crystal clear. We looked at every company in the Wall Street Journal's pharma sector (plus a few others of our own choice), comparing their stock prices on January 1 and December 31, 2007. Then we ranked those companies by percentage increase in stock price. If we'd had the same info at the beginning of last year, these are the 15 stocks we would have chosen. Check out this list of the best pharma stocks of 2007. Report

Suggested Articles

It’s been a rocky road for BMS’ immuno-oncology duo in previously untreated lung cancer, but a new addition to the regimen might hold the ticket.

Novartis’ Zolgensma launch has been anything but boring: First a record price, then a data scandal and now a manufacturing-related delay in Europe.

As CEO Paul Hudson focuses Sanofi's R&D program on immuno-oncology and gene therapies, Sanofi is readying a vaccine plant to make viral vectors.